Antibodies to infliximab in patients treated with either the reference biologic or the biosimilar CT-P13 show identical reactivity towards biosimilars CT-P13 and SB2 in inflammatory bowel disease

被引：0
|
作者：
Fiorino, G. [1 ]
Ruiz-Aguello, M. B. [2 ]
Maguregui, A. [2 ]
Nagore, D. [2 ]
Radice, S. [1 ]
Gilardi, D. [1 ]
Correale, C. [1 ]
Allocca, M. [1 ]
Furfaro, F. [1 ]
Alfieri, M. [1 ]
Martinez, A. [2 ]
Danese, S. [1 ,3 ]
机构：
[1] Humanitas Clin & Res Ctr, Dept Gastroenterol, Milan, Italy
[2] Progenika Biopharma SA, R&D Dept, Derio, Spain
[3] Humanitas Univ, Dept Biomed Sci, Milan, Italy
来源：
JOURNAL OF CROHNS & COLITIS | 2017年 / 11卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P633
引用
收藏
页码：S403 / S404
页数：2
相关论文
共 50 条
  • [31] Subcutaneous CT-P13 for inflammatory bowel disease
    Baker, Holly
    LANCET GASTROENTEROLOGY & HEPATOLOGY, 2021, 6 (05): : 347 - 347
  • [32] Clinical value of CT-P13 trough levels, an infliximab biosimilar, in the management of inflammatory bowel disease
    Elosua Gonzalez, Alfonso
    Sanz Segura, Patricia
    Oyon Lara, Daniel
    Lopez Garcia, Santiago
    Arroyo Villarino, Maria Teresa
    Alcala Escriche, Maria Jose
    Ollero Domenche, Leticia
    Rodriguez Gutierrez, Cristina
    Nantes Castillejo, Oscar
    MEDICINA CLINICA, 2020, 154 (12): : 475 - 480
  • [33] Real-world data on the infliximab biosimilar CT-P13(Remsima~?) in inflammatory bowel disease
    Jose María Huguet
    Xavier Cortés
    Marta Maia Bosca-Watts
    Marian Aguas
    Nuria Maroto
    Lidia Martí
    Cirilo Amorós
    Jose María Paredes
    World Journal of Clinical Cases, 2021, (36) : 11285 - 11299
  • [34] Real-world data on the infliximab biosimilar CT-P13 (Remsima®) in inflammatory bowel disease
    Maria Huguet, Jose
    Cortes, Xavier
    Maia Bosca-Watts, Marta
    Aguas, Marian
    Maroto, Nuria
    Marti, Lidia
    Amoros, Cirilo
    Maria Paredes, Jose
    WORLD JOURNAL OF CLINICAL CASES, 2021, 9 (36) : 11285 - 11299
  • [35] Loss of efficacy and safety of the switch from infliximab original to infliximab biosimilar(CT-P13) in patients with inflammatory bowel disease
    María Fernanda Guerra Veloz
    Federico Argüelles-Arias
    Luisa Castro Laria
    Belén Maldonado Pérez
    Antonio Benítez Roldan
    Raúl Perea Amarillo
    Vicente Merino Bohórquez
    Miguel Angel Calleja
    ángel Caunedo álvarez
    ángel Vilches Arenas
    World Journal of Gastroenterology, 2018, (46) : 5288 - 5296
  • [36] Biosimilar CT-P13 comparable to infliximab in active RA
    Nature Reviews Rheumatology, 2013, 9 (7) : 382 - 382
  • [37] Loss of efficacy and safety of the switch from infliximab original to infliximab biosimilar (CT-P13) in patients with inflammatory bowel disease
    Guerra Veloz, Maria Fernanda
    Arguelles-Arias, Federico
    Castro Laria, Luisa
    Maldonado Perez, Belen
    Benitez Roldan, Antonio
    Perea Amarillo, Raul
    Merino Bohorquez, Vicente
    Angel Calleja, Miguel
    Caunedo Alvarez, Angel
    Vilches Arenas, Angel
    WORLD JOURNAL OF GASTROENTEROLOGY, 2018, 24 (46) : 5288 - 5296
  • [38] CT-P13 biosimilar is non-inferior to infliximab
    Dickson I.
    Nature Reviews Gastroenterology & Hepatology, 2019, 16 (6) : 326 - 326
  • [39] Switching From Reference Infliximab to Biosimilar CT-P13 Did Not Change Quality of Life in Stable Inflammatory Bowel Disease Patients
    Pierik, Marieke J.
    van der Meulen, Andrea E.
    van der Linde, Klaas
    Lutgens, Maurice
    Kuijvenhoven, Johan P.
    Akol, Halil
    Klompmaker, Ids J.
    Sikkens, Michelle S. G.
    van Megen, Yvonne J. B.
    Stoop, Corinne M.
    Bloemsaat-Minekus, Joanne P. J.
    Dijkstra, Gerard
    CROHNS & COLITIS 360, 2022, 4 (03)
  • [40] Switching from reference infliximab to CT-P13 in patients with inflammatory bowel disease: 12 months results
    Arguelles-Arias, Federico
    Guerra Veloz, Maria Fernanda
    Perea Amarillo, Raul
    Vilches-Arenas, Angel
    Castro Laria, Luisa
    Maldonado Perez, Belen
    Chaaro Benallal, Dina
    Benitez Roldan, Antonio
    Merino, Vicente
    Ramirez, Gabriel
    Angel Calleja-Hernandez, Miguel
    Caunedo Alvarez, Angel
    Romero-Gomez, Manuel
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2017, 29 (11) : 1290 - 1295
12345